Literature DB >> 10077041

Neoadjuvant therapy.

J E Niederhuber.   

Abstract

Mesh：

Year:  1999        PMID： 10077041      PMCID： PMC1191694          DOI： 10.1097/00000658-199903000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  25 in total

1.  Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience.

Authors:  S D Merajver; B L Weber; R Cody; D Zhang; M Strawderman; K A Calzone; V LeClaire; A Levin; J Irani; M Halvie; D August; M Wicha; A Lichter; L J Pierce
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

2.  Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma.

Authors:  B Nakata; K H Chung; K Muguruma; Y Yamashita; T Inoue; T Matsuoka; N Onoda; Y Kato; M Sakurai; M Sowa
Journal:  Cancer       Date:  1998-07-01       Impact factor: 6.860

3.  Combined therapy for cancer of the anal canal: a preliminary report.

Authors:  N D Nigro; V K Vaitkevicius; B Considine
Journal:  Dis Colon Rectum       Date:  1974 May-Jun       Impact factor: 4.585

4.  Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy.

Authors:  D M D'Ugo; R Persiani; F Caracciolo; P Ronconi; C Coco; A Picciocchi
Journal:  Surg Endosc       Date:  1997-12       Impact factor: 4.584

5.  Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.

Authors:  A M Lowy; P F Mansfield; S D Leach; R Pazdur; P Dumas; J A Ajani
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

6.  Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report.

Authors:  P Crookes; C G Leichman; L Leichman; M Tan; L Laine; S Stain; J Baranda; Y Casagrande; S Groshen; H Silberman
Journal:  Cancer       Date:  1997-05-01       Impact factor: 6.860

7.  Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer.

Authors:  G W Couper; D McAteer; F Wallis; M Norton; A Welch; M Nicolson; K G Park
Journal:  Br J Surg       Date:  1998-10       Impact factor: 6.939

8.  Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy.

Authors:  C S Ng; J E Husband; A D MacVicar; P Ross; D C Cunningham
Journal:  Clin Radiol       Date:  1998-06       Impact factor: 2.350

9.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.

Authors:  G Rosen; R C Marcove; B Caparros; A Nirenberg; C Kosloff; A G Huvos
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

10.  Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.

Authors:  W Yu; I Whang; I Suh; A Averbach; D Chang; P H Sugarbaker
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969
View more
  2 in total

1.  Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication.

Authors:  Yanlei Ma; Huanlong Qin; Qi Zheng; Yu Wang; Zhiguo Wang; Zhe Yang
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

2.  Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.

Authors:  Zhipeng Sun; Nengwei Zhang
Journal:  World J Surg Oncol       Date:  2014-12-29       Impact factor: 2.754
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.